NESACAINE CE 2% INJ 20MG/ML 20 MG
CHLOROPROCAINE HYDROCHLORIDE : 20 MG · DIN 00613304 · ASTRAZENECA CANADA INC
Health Canada status: CANCELLED POST MARKET
What is NESACAINE CE 2% INJ 20MG/ML?
NESACAINE CE 2% INJ 20MG/ML 20 MG contains CHLOROPROCAINE HYDROCHLORIDE : 20 MG. It is listed in the Health Canada Drug Product Database under DIN 00613304, held by ASTRAZENECA CANADA INC, supplied as SOLUTION for EPIDURAL ; INTRACAUDAL administration. Health Canada currently lists it as cancelled post market, status dated 31-May-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is NESACAINE CE 2% INJ 20MG/ML used for?
NESACAINE (chloroprocaine hydrochloride) is indicated for the production of local anesthesia by infiltration and regional nerve block, including caudal and epidural blocks. Any unused portion should be discarded.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00613304 |
|---|---|
| Brand name | NESACAINE CE 2% INJ 20MG/ML |
| Generic / active ingredient | CHLOROPROCAINE HYDROCHLORIDE : 20 MG |
| Manufacturer | ASTRAZENECA CANADA INC |
| Strength | 20 MG |
| Dosage form | SOLUTION |
| Route of administration | EPIDURAL ; INTRACAUDAL |
| Schedule | Ethical |
| ATC code | N01BA04 CHLOROPROCAINE |
| AHFS class | 72:00.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 31-May-2012 |
| Original market date | 1984-12-31 00:00:00 |
How is it stored and handled?
Keep from freezing. Protect from light. Store at controlled room temperature: 15-30°C.
How is it supplied?
20 mL single use vials
What can be used instead?
Other Canadian products sharing ATC code N01BA04 CHLOROPROCAINE. 1 of 3 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CLOROTEKAL | 10 MG | SOLUTION | B. BRAUN MELSUNGEN AG | MARKETED | DIN 02551063 |
| NESACAINE CE 3% INJ 30MG/ML | 30 MG | SOLUTION | ASTRAZENECA CANADA INC | CANCELLED POST MARKET | DIN 00613312 |
Who else supplies CHLOROPROCAINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. CHLOROPROCAINE appears in 3 registered pack listings across 2 markets, published on 2 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.